Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Evoke Pharma Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EVOK is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 0
- −15 vs. Q3 2025
- Shares held
- 0
- −590.7K (−100.0%) vs. Q3 2025
- Total value
- $0
- −$2.94M (−100.0%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 15
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 15 | $2.94M |
| Q2 2025 | 10 | $603.6K |
| Q1 2025 | 10 | $678.2K |
| Q4 2024 | 8 | $965.6K |
| Q3 2024 | 12 | $994.6K |
| Q2 2024 | 16 | $1.67M |
| Q1 2024 | 15 | $1.93M |
| Q4 2023 | 11 | $71.8K |
| Q3 2023 | 11 | $92.4K |
| Q2 2023 | 11 | $97.4K |
| Q1 2023 | 12 | $131.1K |
| Q4 2022 | 12 | $161.2K |
| Q3 2022 | 11 | $117.0K |
| Q2 2022 | 13 | $228.0K |
| Q1 2022 | 22 | $987.0K |
| Q4 2021 | 25 | $1.13M |
| Q3 2021 | 23 | $5.46M |
| Q2 2021 | 22 | $6.17M |
| Q1 2021 | 25 | $7.83M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Evoke Pharma Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 0 | $0 | 0.00% | −159,358−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −148,153−100.0% | Sold out |
| Bleichroeder LP | 0 | $0 | 0.00% | −146,395−100.0% | Sold out |
| National Wealth Management Group, LLC | 0 | $0 | 0.00% | −80,130−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −23,742−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −18,759−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,437−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −3,010−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −12−100.0% | Sold out |